Close Menu

NEW YORK (GenomeWeb News) – Investment bank Thomas Weisel Partners has initiated coverage of Waters with an "overweight" rating on the firm's stock.

Analyst Peter Lawson wrote in a research note Thursday that Waters received an "overweight" rating because of three factors: its "industry-leading position in the life science space with industry high operating margins; its better-than-peer execution on earnings growth, organic revenue growth, and earnings consistency; and its discount valuation versus both peers and historical levels."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.